Isolagen Announces Date For Annual Meeting
September 26 2006 - 8:07PM
PR Newswire (US)
EXTON, Pa., Sept. 26 /PRNewswire-FirstCall/ -- Isolagen, Inc.
(AMEX:ILE) announced today that it has scheduled its 2006 annual
meeting of stockholders for 10 a.m. on October 24, 2006. The
meeting will be held at The Ritz- Carlton, Ten Avenue of the Arts,
Philadelphia, PA 19102. The record date for shareholders entitled
to vote at the annual meeting is August 30, 2006. ABOUT ISOLAGEN,
INC. Isolagen specializes in the development and commercialization
of autologous cellular therapies for soft and hard tissue
regeneration. The company's product candidates are based on its
proprietary Isolagen Process. Autologous cellular therapy is the
process whereby a patient's own cells are extracted, allowed to
multiply and then injected into the patient. Isolagen's product
candidates are designed to be minimally invasive and non-surgical.
For additional information, please visit: http://www.isolagen.com/
. This press release includes statements that are "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 and the provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. While management has
based any forward-looking statements contained in the release on
its current expectations, the information on which such
expectations were based may change. These forward-looking
statements rely on a number of assumptions concerning future events
and are subject to a number of risks, uncertainties, and other
factors, many of which are outside of Isolagen's control, that
could cause actual results to materially differ from such
statements. Such risks, uncertainties, and other factors include,
but are not necessarily limited to, those set forth under the
caption "Item 1A. Risk Factors" in Isolagen's most recent Form 10-K
filing, as updated in "Item 1A. Risk Factors" in Isolagen's most
recent Form 10-Q filing. In addition, Isolagen operates in a highly
competitive and rapidly changing environment, and new risks may
arise. Accordingly, investors should not place any reliance on
forward-looking statements as a prediction of actual results.
Isolagen disclaims any intention to, and undertakes no obligation
to, update or revise any forward-looking statement. Readers are
also urged to carefully review and consider the various disclosures
in Isolagen's annual report on Form 10-K, filed with the SEC on
March 14, 2006, as well as other public filings with the SEC since
such date. DATASOURCE: Isolagen, Inc. CONTACT: investors, Lee M.
Stern of The Trout Group, +1-212-477-9007, or ; or media, Mike
Beyer of Sam Brown Inc., +1-773-463-4211 or , both for Isolagen,
Inc. Web site: http://www.isolagen.com/
Copyright
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Isolagen (AMEX:ILE)
Historical Stock Chart
From Jul 2023 to Jul 2024